Sugi Predict

Sugi Predict / Compounds / SCHEMBL3588710

SCHEMBL3588710

SCHEMBL3588710

COc1cccc(CS(N)(=O)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.56
▸ IDO1 P14902 2/20 0.56
▸ AGXT P21549 2/20 0.56
▸ CA1 P00915 3/20 0.52
▸ CA2 P00918 3/20 0.52
▸ CA9 Q16790 3/20 0.52
▸ CA5A P35218 1/20 0.52
▸ CMA1 P23946 1/20 0.51
▸ AOC3 Q16853 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ MAOB P27338 2/20 0.49
▸ CHRM2 P08172 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ CHRM3 P20309 1/20 0.49
▸ CA7 P43166 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20502480 0.98 IDO1 (0.57) TAAR1IDO1AGXTCA1CA2
SCHEMBL2718014 0.85 TAAR1 (0.55) TAAR1IDO1AGXTCMA1AOC3
SCHEMBL28142535 0.84 TAAR1 (0.53) TAAR1IDO1AGXTCMA1AOC3
SCHEMBL15876075 0.84 TAAR1 (0.53) TAAR1IDO1AGXTCMA1ALDH1A1
SCHEMBL6011474 0.84 TAAR1 (0.53) TAAR1IDO1AGXTCMA1AOC3
SCHEMBL5117104 0.83 TAAR1 (0.62) TAAR1IDO1AGXTCA1CA2
SCHEMBL28552031 0.82 TAAR1 (0.49) TAAR1IDO1AGXTCA1CA2
SCHEMBL18602238 0.82 TAAR1 (0.51) TAAR1IDO1AGXTCMA1AOC3
SCHEMBL2934451 0.82 TAAR1 (0.51) TAAR1IDO1AGXTCMA1ALDH1A1
SCHEMBL9421746 0.82 FAAH (0.52) TAAR1IDO1AGXTCMA1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111526877-B Compounds and compositions for IRE1 inhibition 奥普提卡拉公司 2023-08-25 — — CN claimed
EP-3675858-B1 IMIDAZO[1,5-A]PYRAZINE COMPOUNDS AND COMPOSITIONS FOR IRE1 INHIBITION OPTIKIRA LLC (US) 2023-04-26 — — EP claimed
CN-119219808-A Multifunctional ionic polymer, preparation method and application thereof, and ion exchange membrane 佛山绿动氢能科技有限公司 2024-12-31 — — CN disclosed
US-11773058-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2023-10-03 — — US disclosed
US-11773058-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2023-10-03 — — US disclosed
CN-111526877-B Compounds and compositions for IRE1 inhibition 奥普提卡拉公司 2023-08-25 — — CN disclosed
US-11518739-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2022-12-06 — — US disclosed
US-20200331850-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-10-22 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20200216389-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-07-09 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
WO-2019034697-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2019-02-21 — — WO disclosed
US-8299021-B2 Macrocyclic inhibitors of hepatitis C virus replication INTERMUNE, INC. (US) 2012-10-30 — — US disclosed
US-20120208995-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION ARRAY BIOPHARMA, INC. (US) 2012-08-16 — — US disclosed
US-20100069350-A1 New Pyridine Analogues III ASTRAZENECA AB (SE) 2010-03-18 — — US disclosed
EP-2044050-A1 NEW PYRIDINE ANALOGUES Astra Zeneca AB (SE) 2009-04-08 — — EP disclosed
US-20080176827-A1 New Pyridine Analogues VII 543 ASTRAZENECA AB (SE) 2008-07-24 — — US disclosed
WO-2008085118-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS. ASTRAZENECA AB (SE) 2008-07-17 — — WO disclosed
US-20080039437-A1 New Pyridine Analogues III ASTRAZENECA AB (SE) 2008-02-14 — — US disclosed
WO-2008004946-A1 NEW PYRIDINE ANALOGUES ASTRAZENECA AB (SE) 2008-01-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216389-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS NLRP3, NOD1, PYCARD TAAR1 2555/4885IDO1 1701/4885AGXT 1421/4885
US-20080176827-A1 New Pyridine Analogues VII 543 P2RY12, P2RY11, P2RY4 TAAR1 231/4885IDO1 2306/4885AGXT 3679/4885
US-11773058-B2 Sulfonamide carboxamide compounds NLRP3, NOD1, NLRP1 TAAR1 1368/4885IDO1 2874/4885AGXT 1999/4885
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 TAAR1 3134/4885IDO1 487/4885AGXT 3671/4885
US-20080039437-A1 New Pyridine Analogues III P2RY12, P2RY1, P2RY11 TAAR1 1018/4885IDO1 2043/4885AGXT 3606/4885
US-20100069350-A1 New Pyridine Analogues III P2RY12, P2RY11, P2RY1 TAAR1 146/4885IDO1 2369/4885AGXT 3810/4885
US-20200331850-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS NLRP3, NOD1, NLRP1 TAAR1 1547/4885IDO1 2938/4885AGXT 1874/4885
US-20120208995-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION EIF2AK2, HAVCR2, HCCS TAAR1 4747/4885IDO1 2573/4885AGXT 95/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 TAAR1 3134/4885IDO1 487/4885AGXT 3671/4885
US-11518739-B2 Sulfonamide carboxamide compounds NLRP3, PYCARD, NOD1 TAAR1 2561/4885IDO1 1904/4885AGXT 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.